Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – 9,10-seco- cyclopentanohydrophenanthrene ring system doai
Patent
1989-11-22
1991-07-30
Ivy, C. Warren
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
9,10-seco- cyclopentanohydrophenanthrene ring system doai
549453, 540116, A61K 3159, C07J 900
Patent
active
050360612
ABSTRACT:
The present invention provides novel derivatives of vitamin D.sub.2 and more specifically 1 alpha,25-dihydroxylated compounds of the vitamin D series. A process for the preparation of such derivatives is also provided as are certain intermediates in such process.
The derivatives of this invention find ready application as substitutes for vitamin D.sub.3 or D.sub.2 or various of the known vitamin metabolites of these vitamins in their various applications to the correction of disorders involving calcium metabolism and associated bone disease.
REFERENCES:
patent: 4225596 (1980-09-01), DeLuca
patent: 4260549 (1981-04-01), DeLuca et al.
patent: 4267117 (1981-05-01), Salmond
patent: 4269777 (1981-05-01), DeLuca et al.
patent: 4448721 (1984-05-01), DeLuca et al.
Salmond et al, Tetrahedron Letters, No. 20, pp. 1695-1698, 1977.
Master's Thesis "Structure Function Relationships of Synthetic and Natural Analogs of Vitamin D" by Lorraine E. Reere, 1977, pp. 78-95.
DeLuca Hector F.
Schnoes Heinrich K.
Sicinski Rafal R.
Tanaka Yoko
Ivy C. Warren
Northington-Davis Zinna
LandOfFree
Process for the preparation of 1 alpha,25-dihydroxylated vitamin does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Process for the preparation of 1 alpha,25-dihydroxylated vitamin, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Process for the preparation of 1 alpha,25-dihydroxylated vitamin will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1542732